Comparative in-vitro activity of SCH 27899, a novel everninomicin, and vancomycin

Journal of Antimicrobial Chemotherapy

Volumn 37, Issue 2, 1996, Pages 361-364

  Urban, Carl ^a,b   Mariano, Noriel ^a   Mosinka Snipas, Kathryn ^a   Wadee, Charles ^a   Chahrour, Tarek ^a   Rahal, James J ^a,b  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; EVERNIMICIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STAPHYLOCOCCUS;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; VANCOMYCIN;

EID: 0029863758     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/37.2.361     Document Type: Article

References (11)

1. Arthur, M. & Courvalin, P. (1993). Genetics and mechanisms of glycopeptide resistance in Enterococci. Antimicrobial Agents and Chemotherapy 37, 1563-71.
2. Black, J., Calesnick, B., Falco, F. G. & Weinstein, M. J. (1964). Pharmacological properties of everninomicin D. Antimicrobial Agents and Chemotherapy 4, 38-46.
3. Cacciapuoti, A., Naples, L., Loebenberg, D., Moss, E. L., Hare, R. S. & Miller, G. H. (1985). In vitro antibacterial activity of SCH 27899, everninomicin antibiotic. In Program and Abstracts of the Twenty-Fifth Interscience Conference on Antimicrobial Agents and Chemotherapy, Minneapolis, 1985. Abstract 803. American Society for Microbiology, Washington, DC.
4. Collins, L. A. Malanoski, G. J., Eliopoulos, G. M. Wennersten, C. B., Ferraro, M. J. & Mollering, R. C. (1993). In vitro activity of RP 59500, an injectable streptogramin antibiotic, against vancomycin-resistant gram-positive organisms. Antimicrobial Agents and Chemotherapy 37, 598-601.
5. Ganguly, A. K., Pramanik B., Chan, T. M., Sarre, O., Liu, Y.-T., Morton, J. & Girijavallabhan, V. (1989). The structure of new oligosaccharide antibiotics, 13-384 components 1 and 5. Heterocycles 28, 83-8.
6. Marquez, J. A., Gullo, V. B., Horan, A., Kalyanpur, M., Miller G., Patel, M. et al. (1985). In vitro antibacterial activity of SCH 27899, everninomicin antibiotic. In Program and abstracts of the Twenty-Fifth Interscience Conference on Antimicrobial Agency and Chemotherapy, Minneapolis, 1985. Abstract 802. Society for Microbiology, Washington, DC.
7. Murray, B. E. (1991). New aspects of antimicrobial resistance and the resulting therapeutic dilemmas. Journal of Infectious Diseases 163, 1185-94.
8. National Committee for Clinical Laboratory Standards. (1990). Methods for Dilution in Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, 2nd edn; Approved Standard M7-A2. NCCLS, Villanova, PA.
9. Sahgal, V. S., Urban, C., Mariano, N., Weinbaum, F., Turner, J. & Rahal, J. J. (1995). Quinupristin/Dalfopristin (RP 59500) therapy for vancomycin-resistant Enterococcus faecium aortic graft infection: case report. Microbial Drug Resistance 1, 245-7.
10. Urban, C., Mariano, N., Moskinka-Snipas, K., Wadee, C., Chahrour, T. & Rahal, J. J. (1993). Comparative in vitro activity of SCH 27899, a novel everninomicin. In Program and Abstracts of the Thirty-Third Conference on Antimicrobial Agents and Chemotherapy, New Orleans, 1993. Abstract 463. American Society for Microbiology, Washington, DC.
11. Weinstein, M. J., Luedemann, G. M., Oden, E. M. & Wagman, G. H. (1964). Everninomicin, a new antibiotic complex from Micromonospora carbonacea. Antimicrobial Agents and Chemotherapy 4, 24-32.